Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
182.2 GBX | -1.30% | -1.83% | +7.43% |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
03-19 | Essentra makes profit but revenue declines, CFO plans to retire | AN |
Sales 2024 * | 334M 426M 582M | Sales 2025 * | 356M 453M 618M | Capitalization | 525M 669M 913M |
---|---|---|---|---|---|
Net income 2024 * | 20M 25.49M 34.78M | Net income 2025 * | 29M 36.97M 50.43M | EV / Sales 2024 * | 1.77 x |
Net Debt 2024 * | 67.93M 86.59M 118M | Net Debt 2025 * | 51.62M 65.8M 89.78M | EV / Sales 2025 * | 1.62 x |
P/E ratio 2024 * |
25.4
x | P/E ratio 2025 * |
17.1
x | Employees | 2,978 |
Yield 2024 * |
2.13% | Yield 2025 * |
2.42% | Free-Float | 94.34% |
Latest transcript on Essentra plc
1 day | -1.30% | ||
1 week | -1.83% | ||
Current month | +3.17% | ||
1 month | +4.47% | ||
3 months | +11.10% | ||
6 months | +16.05% | ||
Current year | +7.43% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Fawcett
CEO | Chief Executive Officer | 53 | 22-12-31 |
Jack Clarke
DFI | Director of Finance/CFO | 59 | 22-04-03 |
Sam Edwrards
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Lester
CHM | Chairman | 75 | 15-12-22 |
Ralf Wunderlich
BRD | Director/Board Member | 58 | 17-06-30 |
Kathryn Durrant
BRD | Director/Board Member | - | 22-12-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 746 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 182.2 | -1.30% | 337,180 |
24-05-20 | 184.6 | 0.00% | 391,757 |
24-05-17 | 184.6 | +1.65% | 340,943 |
24-05-16 | 181.6 | -1.20% | 805,888 |
24-05-15 | 183.8 | -0.97% | 347,568 |
Delayed Quote London S.E., May 21, 2024 at 11:35 am
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.43% | 667M | |
+25.30% | 9.45B | |
+24.94% | 6.69B | |
+13.83% | 4.92B | |
+17.85% | 5.24B | |
+32.94% | 4.66B | |
-25.19% | 2.86B | |
-24.06% | 2.72B | |
-0.72% | 2.52B | |
-1.49% | 2.53B |
- Stock Market
- Equities
- ESNT Stock